First Tissue Bank outside the US to receive AATB accreditation for Human Birth Tissue


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ LifeCell
LifeCell Receives Accreditation From American Association of Tissue Banks

LifeCell International, India's premier human cells tissues and genetics services provider, has now received accreditation from the American Association of Tissue Banks (AATB) for its birth tissue products. This accreditation positions LifeCell as the first & only company not only in India but also outside the US to receive this accreditation. This accreditation certifies the entire process of consent, birth tissue acquisition, processing, release, storage and distribution.

Birth tissue products include the placenta, umbilical cord, and amniotic fluid. Of these the most widely used product is the placental amniotic membrane, which is used as a biological bandage for management of wounds in a variety of specialities such as podiatry, ophthalmology, burns, gynaecology, general and plastic surgery.

This membrane is distributed in a sterile and dehydrated form and used as an intervention when standard wound care has failed. Over 200 growth factors, cytokines and speciality proteins, that are naturally present in the tissue, act as a catalyst for wound closure enabling a quick healing process. A fast and effective wound healing process would substantially decrease medical & hospitalisation costs, treatment period and significantly improve patients' quality of life.

The birth tissue products can be stored at room temperature at hospitals / pharmaceutical outlets without requiring any special storage requirements. Most importantly it can be used on any person without requiring any tissue matching criteria.

With these significant advantages, the rising awareness in the recent past has led to a surge in usage of these birth tissue products. The global market for birth tissue-derived membrane was valued at USD 2.26 Billion in 2017 with an estimated growth of 12% annually.

LifeCell will soon launch the product in India under the brand "Amchoplast" from its a manufacturing facility in Chennai.

Mr. Mayur Abhaya, Managing Director, LifeCell said, "India is the world's largest birthing country and therefore provides a natural opportunity for India to a leading supplier of these issues in the world. LifeCell aims to be a global market leader in this category and with this AATB accreditation we would soon set our foot-prints in the global export market to meet the growing demand for birth tissue products."

The American Association of Tissue Banks (AATB) is a professional, non-profit, scientific organization dedicated to improving and saving lives by promoting the safety, quality and availability of donated human tissue. The American Association of Tissue Banks is the premier standard-setting body promoting the safety and use of donated human tissue. AATB publishes standards, accredits tissue banks and certifies personnel and is the only national tissue banking organization in the United States.

Tags : #lifecell #aatb #firstusaaccredition #tissue #human #birth #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026